HC class I and II molecules bind peptides that are either recognized as self or as foreign to the immune system via interaction with T-cell receptors. The T-cell receptor makes molecular contacts with the peptide and the MHC molecule in the region of the MHC peptide binding cleft. The MHC class I and II molecules are highly polymorphic, which presumably allows for great diversity of antigen-binding sites over the population, leading to a species that is relatively fit to withstand foreign pathogens. In MHC class I molecules, this allelic variation predicts extensive variation in the sequence of peptides able to bind MHC class I molecules, and this is indeed the case. However, in MHC class II molecules, there is an endogenous, default peptide, termed class II associated invariant peptide (CLIP) that occupies the polymorphic binding cleft of~70% of the MHC class II molecules on the cell surface, that is, instead of these molecules binding either other self-peptides or foreign peptides.
The basis for this binding universality, that is, the capacity for CLIP to bind many allelic MHC class II variants, has never been explained.
Several factors determine which peptide binds to which MHC class I or II allelic variant. For example, evidence indicates that certain MHC class I polymorphic variants can attain high-affinity binding with antigenic peptides independently of catalytic factors, whereas other polymorphic variants rely heavily on tapasin and the peptide loading complex for the highest affinity of MHC class I-peptide associations. 1-3 Likewise, MHC class II polymorphic variants are essentially dependent on HLA-DM, which facilitates the removal of the invariant chain from the MHC class II molecule, thereby facilitating a successful competition by the peptide for the MHC class II peptide binding site. 4 Nevertheless, there remains a fundamental difference between MHC class I and II binding mechanisms and affinities for peptides, with many polymorphic variants of MHC class II binding the default, invariant endogenous peptide, class II associated invariant peptide (CLIP), in lieu of MHC class II binding to other self or non-self peptides, allowing for surface transport of an MHC class II-CLIP complex. Under certain conditions, most of the MHC class II on the cell surface is occupied by CLIP. 5, 6 Although low-stringency binding of myriad peptides does occur for MHC class I molecules, these are replaced via the tapasin-peptide loading complex and, if not, the MHC class I-peptide complex is insufficiently stable for cell surface transport. 7 This raises the question of how, from a biochemical standpoint, a single, invariant peptide can relatively tightly occupy the binding cleft of so many polymorphic variants of MHC class II that are expected to vary sufficiently and biochemically, from an evolutionary standpoint, and still meet the goals of both specificity and selectivity throughout the population.
Many biologically active proteins or regions of proteins are characterized by the lack of stable, well-defined three-dimensional structures. 8, 9 Although ordered proteins represent highly specific binding sites for interaction partners, intrinsically disordered proteins are characterized by structural heterogeneity and conformational flexibility that allows for the accommodation of multiple interaction partners. 10 To obtain an initial appreciation for the relative level of intrinsic disorder for CLIP, we analyzed the invariant chain amino acid sequence with four distinct algorithms of the PONDR family to assess intrinsic disorder. PONDR VSL2 is one of the more accurate stand-alone disorder predictors. PONDR VL3 is characterized by a high accuracy for predicting long intrinsically disordered regions. Although the overall accuracy of PONDR VLXT is not high, this predictor has a high sensitivity to local sequence peculiarities that are often associated with disorder-based interaction sites. Metapredictor PONDR FIT is one of the most accurate disorder predictors; it is moderately more accurate than each of its six component predictors, which are PONDR VLXT, PONDR VSL2, PONDR VL3, FoldIndex, IUPred and TopIDP. In these analyses, scores above 0.5 correspond to disordered residues/regions. In all four cases, the CLIP region of the invariant chain is characterized by very high level of intrinsic disorder (Figure 1a) .
We extended the intrinsic disorder analyses by comparing CLIP with the V-regions for the T-cell receptor-α (TcR-α) and TcR-β proteins, keeping in mind that these regions must contact the highly polymorphic region of MHC class II (Figure 1b) . Compared to the entire range of the amino acid sequences of two TcR-α and TcR-β V-regions, which represent the lower and upper examples for the intrinsic disorder for 20 TcR V-regions, the CLIP intrinsic disorder evaluation over the range of the peptide indicates that for all four intrinsic disorder evaluation algorithms, CLIP is dramatically more disordered (Figure 1b) . A comparison of the CLIP disorder range and the range for 20 TcR-α and 20 TcR-β V-regions emphasizes this unusual level of CLIP intrinsic disorder, for both the human and mouse CLIP-TcR comparisons (Figures 1c and d, respectively) .
To ensure that there was no fundamental difference between primary MHC class II peptide groove binding and the binding of the TcRs to the polymorphic edges of the groove, we generated a comparison of the CLIP intrinsic disorder with the intrinsic disorder rate among 501 MHC class II binding 
